Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00142
|
|||||
Drug Name |
L-alanine
|
|||||
Synonyms |
(2S)-2-Aminopropanoic acid; (C14)L-Alanine; (L)-Alanine; (S)-(+)-Alanine; (S)-2-Aminopropanoic acid; (S)-2-Aminopropionic acid; (S)-2-Aminopropionsaeure; (S)-Alanine; (S)-alpha-Aminopropionsaeure; 14C-L-Alanine; 2-Aminopropionic acid; A-Alanine; A-Aminopropionic acid; ALA; Alanina; Alanina [DCIT,Spanish]; Alanine; Alanine (USP); Alanine (VAN); Alanine [USAN:INN]; Alanine, L-(7CI,8CI); Alaninum; Alaninum [Latin]; Alpha-Alanine; Alpha-Aminopropionic acid; F4F207FF-8FF8-4789-99A1-147AE0A36673; H-Ala-OH; L-&alpha-alanine; L-(+)-Alanine; L-2-Aminopropanoic acid; L-2-Aminopropionic acid; L-2-Aminopropionsaeure; L-A-Aminopropionicacid; L-Alanin; L-Alanine (9CI); L-Alanine (JAN); L-Alanine, N-coco alkyl derivs.;Propanoic acid, 2-amino-, (S); L-Alanine, homopolymer; L-Alanine, labeled with carbon-14; L-Alanine, labeled with tritium; L-S-Aminopropionic acid; L-a-Alanine; L-a-Aminopropionic acid; L-alpha-Aminopropionic acid; L-alpha-alanine; LPG; Poly-DL-alanine; Poly-L-alanine; Polyalanine
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Dietary shortage [ICD11: 5B7Z] | Approved | [1] | |||
Glioma [ICD11: 2A00.0] | Approved | [1] | ||||
Therapeutic Class |
Dietary supplement
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C3H7NO2
|
|||||
Canonical SMILES |
CC(C(=O)O)N
|
|||||
InChI |
InChI=1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)/t2-/m0/s1
|
|||||
InChIKey |
QNAYBMKLOCPYGJ-REOHCLBHSA-N
|
|||||
CAS Number |
CAS 56-41-7
|
|||||
Pharmaceutical Properties | Molecular Weight | 89.09 | Topological Polar Surface Area | 63.3 | ||
Heavy Atom Count | 6 | Rotatable Bond Count | 1 | |||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 3 | |||
XLogP |
-3
|
|||||
PubChem CID | ||||||
PubChem SID |
103059020
, 103059733
, 103182286
, 103827139
, 103914796
, 104234104
, 104310701
, 10527484
, 11113404
, 11528607
, 14710664
, 14720011
, 14747373
, 24845820
, 24890849
, 24891241
, 24891260
, 24901893
, 29224973
, 3131856
, 3343
, 46504866
, 46508779
, 49655376
, 56437668
, 57323073
, 57580857
, 585842
, 589753
, 627087
, 6436532
, 78123937
, 7847080
, 7885836
, 7888688
, 8144737
, 8153694
, 822335
, 841591
, 85164877
, 85230829
, 85239779
, 87350317
, 87561861
, 92297527
, 92719579
, 96100165
, 96100173
, 99224270
, 99246016
|
|||||
ChEBI ID |
ChEBI:16977
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | ASCT1 | Transporter Info | Alanine/serine/cysteine/threonine transporter 1 | Substrate | [2] | |
LAT2 | Transporter Info | L-type amino acid transporter 2 | Substrate | [3] | ||
SNAT1 | Transporter Info | Sodium-coupled neutral amino acid transporter 1 | Substrate | [4] | ||
SNAT2 | Transporter Info | Sodium-coupled neutral amino acid transporter 2 | Substrate | [4] | ||
SNAT3 | Transporter Info | Sodium-coupled neutral amino acid transporter 3 | Substrate | [4] | ||
SNAT4 | Transporter Info | Sodium-coupled neutral amino acid transporter 4 | Substrate | [4] | ||
SNAT5 | Transporter Info | Sodium-coupled neutral amino acid transporter 5 | Substrate | [4] | ||
Drug-Transporter Activity Data | ||||||
Drug-Transporter Activity Data | ASCT1 | Transporter Info | Km = 194 microM | Rat hippocampal astrocyte-ASCT1 | [2] | |
References | ||||||
1 | L-alanine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | D-Serine Is a Substrate for Neutral Amino Acid Transporters ASCT1/SLC1A4 and ASCT2/SLC1A5, and Is Transported by Both Subtypes in Rat Hippocampal Astrocyte Cultures. PLoS One. 2016 Jun 7;11(6):e0156551. | |||||
3 | The Transporter Classification Database (TCDB): recent advances. Nucleic Acids Res. 2016 Jan 4;44(D1):D372-9. (ID: 2.A.3.8.20) | |||||
4 | Identification of SLC38A7 (SNAT7) protein as a glutamine transporter expressed in neurons. J Biol Chem. 2011 Jun 10;286(23):20500-11. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.